AzTrials
AzTrials

Qi-Xu; Qi DeficiencyNCT05739266

Pulmonary Function and Qi Deficiency Predicted by Acoustic Analysis

An observational study of Qi-Xu; Qi Deficiency and Pulmonary Function; COPD, run by China Medical University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Acoustic analysis is a method of clinically non-invasive, low-cost, remote-operation, and can avoid direct face-to-face contact. It has been proved by many researches in recent years that it has a high diagnostic rate in predicting diseases. Read more about this study

Who is it for?
Ages 20 years and olderHealthy volunteers can take part
What is being tested?
3 minutes step test
How many people
100 participants
Where
1 siteTaiwan
Study dates
15 Feb 2023to 30 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Students and staffs of China Medical University, Taiwan

Who may be able to join

  • Age: over 20 years old.
  • Agreed and signed Informed Consent Form.

Who cannot join

  • Known heart diseases, acute severe respiratory infection, severe arthritis or other orthopedic disabilities, severe hypertension, or pregnant.

Trial locations and contacts

1 site in 1 country.

Jung- Nien Lai, MD(Doctor of medicine) contact

+886 910915762

ericlai111@gmail.com

Sophie Juang, TCM undergraduate contact

+886 919530929

u108030090@cmu.edu.tw

Taiwan1 site, 1 recruiting
  • No. 2, Yude Road, North District

    Taichung, Taichung City, 404327

    Recruiting

Other trials in Taiwan

About this study

Official title: Prediction of Pulmonary Function and Qi Deficiency Based on the Acoustic Analysis Before and After Step Test

Acoustic analysis is a method of clinically non-invasive, low-cost, remote-operation, and can avoid direct face-to-face contact.

It has been proved by many researches in recent years that it has a high diagnostic rate in predicting diseases. Lung function is closely related to human vocalization and has the potential and need for sound analysis. From literature review, it can be inferred that the Qi deficiency constitution in TCM is related to the strength of heart and lung function.The purpose of this study is to investigate the correlation between cardiopulmonary function and Qi deficiency, and to predict the correlation between the data by computer algorithm and artificial intelligence. Furthermore, the artificial intelligence (AI) self-correction ability can be combined with sound analysis to simulate a sound analysis system that can predict cardiopulmonary function and degree of qi deficiency only through sound information.

Read more

Research motivation and questions:

  1. Is the sound characteristic of an individual related to individual's qi deficiency and cardiopulmonary function?
  2. Can lung function and qi deficiency be measured by sound analysis?
  3. To understand the correlation between Qi deficiency and cardiopulmonary endurance index.
  4. Is there any difference in sound characteristics before and after step test and does it help predicting cardiopulmonary function?
Being tested
3 minutes step test
Keywords
Qi-Xu; Qi deficiency, Pulmonary Function; COPD, Step test; heart recovery rate
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3 minutes step testBehavioural

    3 minutes step test- Stair hight:20 cm, Pace: 96 steps per minute

Study groups in NCT05739266
Study groupRoleWhat they receive
Before step testBefore step test. -Participants record their before-step-test voice.
After step testAfter step test. -Participants record their after-step-test voice.
Receives: Behavioral: 3 minutes step test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. FVC<80%

    FVC<80%

    Measured: 10 mins

  2. FVC>80%

    FVC>80%

    Measured: 10 mins

  3. Qi deficient

    Qi deficient

    Measured: 10 mins

  4. step test: heart rate recovery

    Tecumseh step test.

    Measured: 15 mins

  5. Voice record

    /a/, /e/, /i/, /o/, /u/, five seconds each, 3 times per person

    Measured: 15 mins

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Feb 2023
  2. Study start15 Feb 2023 (estimated)
  3. Primary completion30 Apr 2023 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Cross-sectional
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05739266
Sponsor's protocol ID
CMUH111-REC2-036
Status last verified
Feb 2023
First submitted
12 Feb 2023
Last updated
22 Feb 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Qi-Xu; Qi Deficiency and Pulmonary Function; COPD, run by China Medical University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jung- Nien Lai, MD(Doctor of medicine) (+886 910915762, ericlai111@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

FVC<80% (time frame: 10 mins). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in